Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Beachler, Taylor; Zeller, T Aaron; Heo, Moonseong; Lanzillotta-Rangeley, Jennifer; Litwin, Alain H.

doi:10.1111/jrh.12503

Cited by 37 publications

(20 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following the care coordinator quoted in the results section, this training also may work to reduce stigma, and the role of both public and anticipated stigma as a barrier to care. These findings are consistent with those found by Beachler et al (2021), such that improving health literacy regarding OUD and MOUD can improve attitudes in rural communities. However, trainings were not associated with attitudes related to buprenorphine.…”

Section: Discussionsupporting

confidence: 91%

“…There is also growing evidence that individuals from rural communities with OUD experience stigma across multiple domains—publicly enacted, anticipated, experienced, and internalized—see Turan et al (2017) for a conceptual model), which, along with structural factors (Lister et al, 2020; e.g., lack of access to treatment), generate more expansive barriers to care for rural people who use drugs. There is also little knowledge whether MOUD training may help mitigate these negative attitudes (Beachler, Zeller, Heo, Lanzillotta‐Rangeley, & Litwin, 2021).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders

Victor

Lee

Pozo

et al. 2022

Journal of Drug Issues

View full text Add to dashboard Cite

The aim of this study was to describe rural community stakeholders’ attitudes and perceptions of providing medication for opioid use disorder (MOUD) to individuals in the criminal/legal system. Data were utilized from a technical assistance initiative aimed at strengthening community-based OUD treatment within criminal/legal systems. A mixed-methods approach was applied. Survey responses were used to compare stakeholders’ who had and had not attended an MOUD training, and semistructured interviews were conducted with a convenience sample of rural criminal/legal and treatment stakeholders. MOUD training was associated with endorsing the effectiveness of methadone, oral naltrexone, and injectable naltrexone. Three primary themes emerged from the stakeholder interviews: 1) acceptance of MOUD uptake; 2) stigma of MOUD and diversion concerns; and 3) gaps in MOUD treatment. Most interviewees noted that there is a scarcity of treatment options in their community, and among the existing services, there are considerable barriers to care.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Introductionmentioning

confidence: 99%

Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders

Victor

Lee

Pozo

et al. 2022

Journal of Drug Issues

View full text Add to dashboard Cite

show abstract

“…Rural areas may have substantial stigma toward medication for OUD compared to urban areas [ 25 ]. This stigma of addiction may decrease the willingness of physicians to obtain the waiver to prescribe office-based buprenorphine in the absence of a significant epidemic [ 14 , 15 ]. While stigma against drug use exists in urban areas, urban areas may already have relatively more health care professionals willing to treat addiction.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, the prescribing capacity may not equate to the prescribing frequency. Due to differences in levels of community-level stigma and differences in HCV case rates, these relationships may differ by urban/rural classification [ 5 , 7 , 14 , 15 ].…”

mentioning

confidence: 99%

The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio

Brook

Hetrick

Chettri

et al. 2021

Open Forum Infectious Diseases

View full text Add to dashboard Cite

Background The United States is experiencing an epidemic of hepatitis C virus (HCV) infections due to injection drug use, primarily of opioids and predominantly in rural areas. Buprenorphine, a medication for opioid use disorder, may indirectly prevent HCV transmission. We assessed the relationship of HCV rates and office-based buprenorphine prescribing in Ohio. Methods We conducted an ecological study of the county-level (n = 88) relationship between HCV case rates and office-based buprenorphine prescribing in Ohio. We fit adjusted negative binomial models between the county-level acute and total HCV incidence rates during 2013–2017 and 1) the number of patients in each county that could be served by office-based buprenorphine (prescribing capacity) and 2) the number served by office-based buprenorphine (prescribing frequency) from January–March, 2018. Results For each 10% increase in acute HCV rate, office-based buprenorphine prescribing capacity differed by 1% (95% CI: –1%, 3%). For each 10% increase in total HCV rate, office-based buprenorphine prescribing capacity was 12% (95% CI: 7%, 17%) higher. For each 10% increase in acute HCV rate, office-based buprenorphine prescribing frequency was 1% (95% CI: –1%, 3%) higher. For each 10% increase in total HCV rate, office-based buprenorphine prescribing frequency was 14% (95% CI: 7%, 20%) higher. Conclusions Rural counties in Ohio have less office-based buprenorphine and higher acute HCV rates versus urban counties, but a similar relationship between office-based buprenorphine prescribing and HCV case rates. To adequately prevent and control HCV rates, certain rural counties may need more office-based buprenorphine prescribing in areas with high HCV case rates.

show abstract

“…Stigma toward persons who have a SUD, including Opioid Use Disorder (OUD) in particular, has been well-documented within the general population (15) and among healthcare professionals (16)(17)(18) and has been shown to profoundly impacts patient access to resources, healthcare, and overall quality of life (19)(20)(21). However, general attitudes toward organ transplantation for persons with substance use is largely unknown.…”

Section: Introductionmentioning

confidence: 99%

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

et al. 2021

View full text Add to dashboard Cite

Background: Increases in opioid-related overdose and death have led to increases in the number of organs available for donation and transplant, however persons who have a substance use disorder (SUD) may be disadvantaged relative to other health conditions with regard to receiving an organ for transplant.Objective: This study aimed to evaluate perceptions regarding acceptability and priority for organ donation vs. a control condition (resuscitation) for hypothetical persons with nine target health conditions including a substance use disorder, among persons recruited as part of an online survey.Methods: Respondents (N = 285; male = 172, female = 113) recruited from Amazon Mechanical Turk rated acceptability and priority that hypothetical persons representing nine target health conditions expected to influence transplant success (including a SUD) receive an organ transplant and resuscitation via a survey hosted by Qualtrics. Primary outcomes of stigma ratings and priority ranking of persons as a function of the hypothetical target health condition were analyzed using Repeated Measures Analyses of Variance and Bonferroni-corrected t-tests. Demographic information was presented descriptively for all respondents.Results: Ratings for acceptability and priority for persons who had a SUD were generally lower than ratings for other conditions for both organ for transplant and resuscitation, though respondents reported less stigma toward resuscitation, F(8) = 22.35, p <0.001 overall. Respondents were least supportive of persons who smoked cigarettes receiving an organ, p's < 0.001. Priority rankings favored persons who were young or had a history of heart disease. Multivariable models determined that target health condition, F(8) = 33.64, p < 0.001, was a better and more consistent predictor of response than demographic variables that were examined.Conclusions: Data suggest that general perception of acceptability and priority ranking for receipt of life-saving interventions was lower for persons who have a SUD relative to other clinically-relevant health conditions. Research to examine this effect among persons working in the donation system are warranted and efforts to reduce stigma toward persons who have a SUD should be continued.

show abstract

Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Cited by 37 publications

References 19 publications

Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders

Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders

The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

Contact Info

Product

Resources

About